Condition

SARS-CoV Infection (4)

Covid19 (2)

Acute Respiratory Infection (1)

Allergic Reaction (1)

COVID-19 (1)

Coronavirus (1)

Inflammation (1)

Kidney Diseases (1)

Mast Cell Disorder (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Recruiting (1)

Phase

phase 3 (2)

phase 2 (1)

Sponsor

Massachusetts General Hospital (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Novavax (1)

University of Michigan (1)

Collaborator

Department of Health and Human Services (1)

Immune Tolerance Network (ITN) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Rho Federal Systems Division, Inc. (1)

Study Documents

Intervention Type

biological (2)

diagnostic test (1)

drug (1)

other (1)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (3)

Observational (1)

SARS-CoV Infection

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting

SARS-CoV Infection
Covid19

SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
+5 more

Birmingham, Alabama
+155 more

Dec 16, 2022

SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

Completed

SARS-CoV Infection
+3 more

Moderna COVID-19 Vaccine
+2 more

Tucson, Arizona
+28 more

Sep 19, 2022

Outcomes of Patients Hospitalized for COVID-19

Recruiting

Covid19
+3 more

Biomarkers of inflammation

Ann Arbor, Michigan

University of Michigan

Aug 9, 2022

Coronavirus, Acute Respiratory Infection, SARS-CoV Infection Trial in United States (Hydroxychloroquine, Placebo)

Completed

Has Results

Coronavirus
+2 more

Hydroxychloroquine
Placebo

Tucson, Arizona
+39 more

Mar 12, 2021